通过主动治疗算法优化抗逆转录病毒治疗:荷兰HIV感染者中的成本效益策略
本研究在荷兰两家大型HIV诊所实施ART算法,由药师筛查1年。1596例HIV感染者中840例(52.6%)符合切换条件,处方者接受81.1%的切换建议,84.9%符合条件者同意切换,最终558人接受新方案。
要点
- 药师主导的ART算法筛查可识别52.6%的HIV感染者适合切换至更经济方案。
- 处方者对切换建议的接受率为81.1%,符合条件者的同意率为84.9%。
核心结论
- ART算法在处方者和HIV感染者中接受度高,带来显著成本节约,可易于在其他HIV诊所实施。
研究设计与样本
- 前瞻性研究,在荷兰两家大型HIV诊所实施ART算法,由药师筛查ART方案1年。
主要发现
- 1596例HIV感染者中840例(52.6%)符合切换条件。
- 处方者接受81.1%的切换建议,84.9%符合条件者同意切换,最终558人接受新方案。
- 多拉韦林/富马酸替诺福韦二吡呋酯/拉米夫定(DOR/TDF/3TC)是最常处方的方案(61.6%)。
关键数值与推荐
- 当前ART月费用超过€600,并考虑肾功能和/或肾小管毒性、乙型肝炎状态及耐药史。
临床怎么用
- 药师可筛查ART方案,对病毒学抑制且符合条件者提出切换建议,处方者和感染者接受度高。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A wide range of effective antiretroviral therapy (ART) regimens with favourable side effects are available. More than 70% of HIV care costs in the Netherlands are attributed to ART. We developed an ART algorithm to proactively switch virologically suppressed individuals to a more cost-effective HIV treatment. METHODS: This prospective study implemented our ART algorithm in two large Dutch HIV clinics, where a pharmacist screened ART regimens for 1 year. Individuals were considered suitable for a switch if their current ART exceeded €600 per month, considering renal function and/or tubular toxicity, hepatitis B status, and resistance history. If eligible, advice with a switch proposal was recorded in the patient file. The objective was to investigate the acceptance of the proposal and the effect of proactive switching on the total costs of ARTs. FINDINGS: Of 1596 people living with HIV, 840 (52.6%) were eligible. Prescribers accepted 81.1% of the switch proposals, and 84.9% of eligible individuals agreed to the proposed switch. Ultimately, 558 individuals accepted the new ART regimen proposal, with doravirine/tenofovir disoproxil fumarate/lamuvidine (DOR/TDF/3TC) being the most prescribed (61.6%). The switch led to significant cost savings, reducing annual ART expenditure from €10 923 to €8580 per eligible individual, totalling almost €2 million (-21.4%) in savings annually. INTERPRETATION: Our ART algorithm demonstrated high acceptance by prescribers and people with HIV, leading to substantial cost savings. The algorithm can be easily implemented in other HIV clinics to offer even more significant cost savings to Dutch healthcare payers.
引用
- Oosterhof P, van Luin M, Grintjes K, et al. Optimising antiretroviral therapy through a proactive treatment algorithm: a cost-effective strategy in Dutch healthcare for people with HIV. J Antimicrob Chemother. 2025. PMID: 40219835. doi:10.1093/jac/dkaf117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。